Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Brain Magnetic Susceptibility Changes in Patients with Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

Abstract : We investigated the brain magnetic susceptibility changes induced by natalizumab-associated progressive multifocal leukoencephalopathy. We retrospectively included 12 patients with natalizumab-progressive multifocal leukoencephalopathy, 5 with progressive multifocal leukoencephalopathy from other causes, and 55 patients with MS without progressive multifocal leukoencephalopathy for comparison. MR imaging examinations included T2* or SWI sequences in patients with progressive multifocal leukoencephalopathy (86 examinations) and SWI in all patients with MS without progressive multifocal leukoencephalopathy. Signal abnormalities on T2* and SWI were defined as low signal intensity within the cortex and/or U-fibers and the basal ganglia. We observed T2* or SWI signal abnormalities at the chronic stage in all patients with progressive multifocal leukoencephalopathy, whereas no area of low SWI signal intensity was detected in patients without progressive multifocal leukoencephalopathy. Among the 8 patients with asymptomatic natalizumab-progressive multifocal leukoencephalopathy, susceptibility changes were observed in 6 (75%). The basal ganglia adjacent to progressive multifocal leukoencephalopathy lesions systematically appeared hypointense by using T2* and/or SWI. Brain magnetic susceptibility changes may be explained by the increased iron deposition and constitute a useful tool for the diagnosis of progressive multifocal leukoencephalopathy.
Type de document :
Article dans une revue
Liste complète des métadonnées
Contributeur : Lilloa Université de Lille <>
Soumis le : lundi 18 novembre 2019 - 14:51:15
Dernière modification le : vendredi 16 juillet 2021 - 08:57:19

Lien texte intégral




Jerome Hodel, Olivier Outteryck, Sebastien Verclytte, Vincent Deramecourt, Arnaud Lacour, et al.. Brain Magnetic Susceptibility Changes in Patients with Natalizumab-Associated Progressive Multifocal Leukoencephalopathy. American Journal of Neuroradiology, American Society of Neuroradiology, 2015, AJNR. American journal of neuroradiology, 36 (12), pp.2296-2302. ⟨10.3174/ajnr.A4436⟩. ⟨hal-02368327⟩



Consultations de la notice